ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs MXN
18.4136
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,380.59
0.07%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Sierra Natl BK Tehachapi Calif (MM) (SIRT)

  7. Sierra Natl BK Tehachapi Calif (MM) (SIRT) Noticias

SIRT

Sierra Natl BK Tehachapi Calif (MM) (SIRT)

Sierra Natl BK Tehachapi Calif (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:SIRT
FechaHoraFuenteTítuloSímboloCompañía
05/06/200816:15Edgar (US Regulatory)Sirtris Pharmaceuticals, Inc. - Termination of Registration of a Class of Security under Section 12(b) (15-12B)NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
05/06/200816:14Edgar (US Regulatory)Sirtris Pharmaceuticals, Inc. - Post-Effective Amendment to an S-8 filing (S-8 POS)NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
05/06/200816:13Edgar (US Regulatory)Sirtris Pharmaceuticals, Inc. - Current report filing (8-K)NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
05/06/200816:00Edgar (US Regulatory)Sirtris Pharmaceuticals, Inc.-Notification filed by National Security Exchange to report the removal from listing an... (25-NSE)NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
04/06/200806:00Business WireSirtris Pharmaceuticals Presents at the American Diabetes Association's 68th Annual Scientific Sessions June 8NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
02/06/200817:41PR Newswire (US)Mergent, Inc. Announces Changes to the HealthShares(TM) Metabolic-Endocrine Disorders IndexNASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
02/06/200809:43Edgar (US Regulatory)Sirtris Pharmaceuticals, Inc. - Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
02/06/200809:42Edgar (US Regulatory)Sirtris Pharmaceuticals, Inc. - Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
02/06/200808:54PR Newswire (US)GlaxoSmithKline Successfully Completes Tender Offer for Shares of Sirtris PharmaceuticalsNASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
30/05/200817:24Edgar (US Regulatory)Sirtris Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4)NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
14/05/200812:37Edgar (US Regulatory)Sirtris Pharmaceuticals, Inc. - Quarterly Report (10-Q)NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
02/05/200808:29Edgar (US Regulatory)Sirtris Pharmaceuticals, Inc. - Statement of Ownership: Solicitation (SC 14D9)NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
02/05/200808:15Edgar (US Regulatory)Sirtris Pharmaceuticals, Inc. - Tender offer statement by Third Party (SC TO-T)NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
02/05/200808:00PR Newswire (US)GlaxoSmithKline Commences Tender Offer to Acquire Sirtris PharmaceuticalsNASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
01/05/200815:30Business WireSirtris Pharmaceuticals Reports First Quarter 2008 Financial ResultsNASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
30/04/200809:39PR Newswire (US)Genstruct and Sirtris Pharmaceuticals Win Bio-IT World's Best Practices AwardNASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
29/04/200816:23Edgar (US Regulatory)Sirtris Pharmaceuticals, Inc. - Amended Annual Report (10-K/A)NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
22/04/200816:37PR Newswire (US)GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and DevelopmentNASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
17/04/200807:00Business WireSirtris Announces SRT501 Lowers Glucose in Twice-Daily Dosing Clinical Trial; Study Suggests Dose Response for Proprietary FormuNASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
16/04/200807:00Business WireSirtris Scientific Advisory Board Co-Chairs Publish First In-Vivo Data Showing SIRT1 Enzyme Can Suppress Tumor DevelopmentNASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
02/04/200811:00Business WireADDING MULTIMEDIA Sirtris Receives Orphan Drug Designation from U.S. Food and Drug Administration for Resveratrol in MitochondriNASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
02/04/200807:00Business WireSirtris Receives Orphan Drug Designation from U.S. Food and Drug Administration for Resveratrol in Mitochondrial Disorder, MELASNASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
01/04/200815:17Edgar (US Regulatory)Sirtris Pharmaceuticals, Inc. - Initial Statement of Beneficial Ownership (3)NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
01/04/200807:00Business WireSirtris Pharmaceuticals Presents at American Chemical Society April 7NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
28/03/200807:00Business WireSirtris Pharmaceuticals Scientific Advisor Shows SIRT1 Activation Improves Huntington's Disease In Preclinical ModelNASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
25/03/200807:00Business WireSirtris Pharmaceuticals Announces the Appointment of Paul A. Friedman, M.D., President and CEO of Incyte Corporation, to its BoaNASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
24/03/200815:03Edgar (US Regulatory)Sirtris Pharmaceuticals, Inc. - Annual Report (10-K)NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
24/03/200807:00Business WireSirtris Pharmaceuticals Presents at Future Leaders in the Biotechnology Industry Conference March 27NASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
19/03/200807:00Business WireSirtris Announces First U.S. Patent Issued On Class of SIRT1 Activators; Patent Covers First NCE to Enter Human Clinical TrialsNASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
13/03/200807:00Business WireSirtris Pharmaceuticals Presents at Cowen and Company Health Care Conference & the IBC Life Sciences Metabolic Disorders ConfereNASDAQ:SIRTSierra Natl BK Tehachapi Calif (MM)
 Showing the most relevant articles for your search:NASDAQ:SIRT

Su Consulta Reciente

NYSE
MCD
McDonalds
USI
USTECH100
US Tech 100
NYSE
XOM
Exxon Mobil
USOTC
ADDYY
Adidas (QX)
NASDAQ
GOOGL
Alphabet
AMEX
SPY
SPDR S&P 500
COIN
ETHUSD
Ethereum
CCOM
US30
US 30
NASDAQ
AAPL
Apple
CCOM
US500
US 500
NYSE
VZ
Verizon Communications
COIN
BTCUSD
Bitcoin
AMEX
XLV
Health Care Select Sector
AMEX
XLF
Financial Select Sector
FX
EURUSD
Euro vs US Dollar
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados